One in five has a mutation that provides superior resilience to cold
Almost one in five people lacks the protein α-actinin-3 in their muscle fibre. Researchers at Karolinska Institutet in Sweden now show that more of the skeletal muscle of these individuals comprises slow-twitch muscle fibres, which are more durable and energy-efficient and provide better tolerance to low temperatures than fast-twitch muscle fibres. The results are published in the scientific journal The American Journal of Human Genetics.
Skeletal muscle comprises fast-twitch (white) fibres that fatigue quickly and slow-twitch (red) fibres that are more resistant to fatigue. The protein α-actinin-3, which is found only in fast-twitch fibres, is absent in almost 20 per cent of people – almost 1.5 billion individuals – due to a mutation in the gene that codes for it. In evolutionary terms, the presence of the mutated gene increased when humans migrated from Africa to the colder climates of central and northern Europe.
Better at keeping warm
“This suggests that people lacking α-actinin-3 are better at keeping warm and, energy-wise, at enduring a tougher climate, but there hasn’t been any direct experimental evidence for this before,” says Håkan Westerblad, professor of cellular muscle physiology at the Department of Physiology and Pharmacology, Karolinska Institutet. “We can now show that the loss of this protein gives a greater resilience to cold and we’ve also found a possible mechanism for this.”
For the study, 42 healthy men between the ages of 18 and 40 were asked to sit in cold water (14 °C) until their body temperature had dropped to 35.5 °C. During cold water immersion, researchers measured muscle electrical activity with electromyography (EMG) and took muscle biopsies to study the protein content and fibre-type composition.
Produce heat in a different way
The results showed that the skeletal muscle of people lacking α-actinin-3 contains a larger proportion of slow-twitch fibres. On cooling, these individuals were able to maintain their body temperature in a more energy-efficient way. Rather than activating fast-twitch fibres, which results in overt shivering, they increased the activation of slow-twitch fibers that produce heat by increasing baseline contraction (tonus).
“The mutation probably gave an evolutionary advantage during the migration to a colder climate, but in today’s modern society this energy-saving ability might instead increase the risk of diseases of affluence, which is something we now want to turn our attention to,” says Professor Westerblad.
May affect the response to exercise
Another interesting question is how the lack of α-actinin-3 affects the body’s response to physical exercise.
“People who lack α-actinin-3 rarely succeed in sports requiring strength and explosiveness, while a tendency towards greater capacity has been observed in these people in endurance sports,” he explains.
One limitation of the study is that it is harder to study mechanisms in human studies at the same level of detail as in animal and cell experiments. The physiological mechanism presented has not been verified with experiments at, for example, the molecular level.
The study was a collaboration with research groups at the Lithuanian Sports University in Kaunas, Lithuania, and the University of Melbourne in Australia. It was supported by grants from the Swedish Research Council, the Swedish National Centre for Research in Sports, the Research Council of Lithuania, the Swedish Society for Medical Research, the Jeansson Foundations, the Swedish Heart and Lung Foundation and Australia’s National Health and Medical Research Council. Co-author Volker Lauschke is the founding CEO and shareholder of HepaPredict AB and has been a consultant for EnginZyme AB.
Publication: “Loss of α-actinin-3 during human evolution provides superior cold resilience and muscle heat generation”. Victoria L. Wyckelsma, Tomas Venckunas, Peter J. Houweling, Maja Schlittler, Volker M Lauschke, Chrystal F. Tiong, Harrison D. Wood, Niklas Ivarsson, Henrikas Paulauskas, Nerijus Eimantas, Daniel C. Andersson, Kathryn N. North, Marius Brazaitis, Håkan Westerblad. American Journal of Human Genetics, online 17 February 2021, doi: 10.1016/j.ajhg.2021.01.013.
For more information, please contact:
Håkan Westerblad, professor
Department of Physiology and Pharmacology, Karolinska Institutet
Phone: +46 705 88 95 62
Email: hakan.westerblad@ki.se
Karolinska Institutet is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Tags:
